RxDoctor Payments Data

Amber Martin, DO

Family Medicine · Florence, SCNPI 1053871467

Payments from drug & device makers

$2,789in general payments, 2019–2025

Across 160 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$402
  • Pfizer$180
  • Amgen$173
  • AstraZeneca$128
  • Abbott$124
  • plus $628 from 14 others

What the payments were for

  • Food & beverage$2,789100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,789 in reported general payments places this provider in the 75th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$124,559
Medicare patients
313
Services billed
1,885

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$90,664
EliquisApixaban63$57,478
JardianceEmpagliflozin57$56,818
MounjaroTirzepatide50$55,809
FarxigaDapagliflozin Propanediol23$28,578
EntrestoSacubitril/Valsartan35$21,822
JanuviaSitagliptin Phosphate17$18,288
LinzessLinaclotide22$17,671
VeltassaPatiromer Calcium Sorbitex12$12,841
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,673
Breo ElliptaFluticasone/Vilanterol18$8,778
TradjentaLinagliptin14$8,654
Atorvastatin Calcium375$4,848
Ezetimibe71$3,291
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen151$3,108

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$402$90,66481 claims
PfizerEliquis$180$57,47863 claims
Lilly USA, LLCMounjaro$84$55,80950 claims
AstraZenecaFarxiga$128$28,57823 claims
NovartisEntresto$38$21,82235 claims
AbbVieLinzess, Synthroid$1,154$20,74070 claims
GSKTrelegy Ellipta, Breo Ellipta$47$18,45133 claims
MerckJanuvia$20$18,28817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →